Login to Your Account

JPMorgan H&Q Healthcare Conference

Alexion Starts Phase III Study With Heart Drug Pexelizumab

By Randall Osborne

Tuesday, January 8, 2002
No Abstract

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription